News Focus
News Focus
icon url

wsbc

08/19/21 7:09 PM

#371090 RE: loanranger #371088

Why was the futility of it unanticipated?



...because idiocy?
icon url

Hugon

08/19/21 7:10 PM

#371091 RE: loanranger #371088

That's a fair question, LR. Lemoncat would probably say that it was Polymedix that made this ph2b spend, and not him. That's fair too. So, the bigger question is why ipix keeps doing tiny trials. That's on him, the bigger question. Also, the question is why this platform can't be sold asap if it has the cure for covid, UC, UP and OM and absssi. drugs always being bought, why hasn't brilacidin. it doesn't need a ph3 to sell it. drugs are bought all the time for BILLIONS BEFORE EVEN STARTING PHASE 1. Holy cow. get it done now. Enough small ball and a cpa pretending to play ceo land. time to sell and play with material objects and go on exotic vacations.
icon url

Lemoncat

08/19/21 9:01 PM

#371104 RE: loanranger #371088

I'm with wsbc on this one...."Because of idiocy".

Idiocy by the management of CTIX.
Idiocy by the investors (myself included).

For whatever reason no one decided to consider that our billion dollar comparitor, Cubicin, would be turning into our dirt cheap close-enough generic Daptomycin before we were approved.

Apparently no big pharma believed it would be worth a billion per year like Cubicin likely because they had a modicum of foresight. Something The Accountant, The Veterinarian, and their merry band of sycophants (myself included) lacked.

Should the COVID trial pull through though I bet everyone will wish that phase 3 had been run.

Go IPIX!